Basis for early and preferential selection of the E138K mutation in HIV-1 reverse transcriptase

Matthew McCallum1, Maureen Oliveira, Ruxandra-Ilinca Ibanescu

  • 1McGill University AIDS Centre, Lady Davis Institute of Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Summary

HIV-1 reverse transcriptase (RT) shows a mutational bias, favoring G→A changes like E138K, which impacts drug resistance evolution. This bias is observed both in selection experiments and in drug-naive patients.

Related Concept Videos